Y-mAbs Therapeutics, Inc. (YMAB) Net Income by Year
Y-mAbs Therapeutics, Inc. reported a net loss of $29.7M in fiscal year 2024. This represents a decrease of 38.5% from the prior fiscal year. Over the trailing 12 months, Q3 FY2024 through Q2 FY2025, the same line adds up to a $22.2M net loss. The table below carries 8 fiscal years, from 2017 to 2024, and the quarters Y-mAbs Therapeutics, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
YMAB Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
TTM is the trailing twelve months, Q3 FY2024 through Q2 FY2025, summed from the four most recent quarterly filings.
YMAB Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More Y-mAbs Therapeutics, Inc. financials
Frequently Asked Questions
What was Y-mAbs Therapeutics, Inc.'s net income in fiscal year 2024?
Y-mAbs Therapeutics, Inc. reported a net loss of $29.7M in fiscal year 2024.
How fast is Y-mAbs Therapeutics, Inc.'s net income growing?
Y-mAbs Therapeutics, Inc. (YMAB) net income fell by 38.5% year over year, from -$21.4M to -$29.7M in fiscal year 2024.
What is Y-mAbs Therapeutics, Inc.'s net income over the last twelve months?
Y-mAbs Therapeutics, Inc. (YMAB) reported a $22.2M net loss over the trailing 12 months, Q3 FY2024 through Q2 FY2025, summed from the four most recent quarterly filings.
How has Y-mAbs Therapeutics, Inc.'s net income changed over the years?
Across the 8 fiscal years this page covers, Y-mAbs Therapeutics, Inc. (YMAB) net income went from -$19.2M in fiscal year 2017 to -$29.7M in fiscal year 2024.
What was Y-mAbs Therapeutics, Inc.'s net income in the most recent quarter?
Y-mAbs Therapeutics, Inc. (YMAB) reported -$3.2M in net income in Q2 2025. This represents an increase of 65.0% from the same quarter a year earlier.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Y-mAbs Therapeutics, Inc. (YMAB) reported on that line in every period on record.